Palais de Justice in Paris, France (Shutterstock)
February 17, 2023 03:06 PM EST
Pharma
Law

French court over­turns €444M an­titrust fine against Roche, No­var­tis

Paul Schloesser

Associate Editor

An an­ti-com­pet­i­tive­ness fine has just been re­voked against neigh­bor­ing Swiss phar­ma gi­ants Roche and No­var­tis.

A rul­ing from the Paris Court …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times